000 | 01907 a2200505 4500 | ||
---|---|---|---|
005 | 20250517114245.0 | ||
264 | 0 | _c20170726 | |
008 | 201707s 0 0 eng d | ||
022 | _a1878-3511 | ||
024 | 7 |
_a10.1016/j.ijid.2016.09.002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRafalsky, Vladimir | |
245 | 0 | 0 |
_aEfficacy and safety of Ergoferon versus oseltamivir in adult outpatients with seasonal influenza virus infection: a multicenter, open-label, randomized trial. _h[electronic resource] |
260 |
_bInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases _cOct 2016 |
||
300 |
_a47-55 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntibodies _xtherapeutic use |
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 |
_aCD4 Antigens _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFever _xdrug therapy |
650 | 0 | 4 |
_aHistamine _ximmunology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfluenza, Human _xdrug therapy |
650 | 0 | 4 |
_aInterferon-gamma _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOseltamivir _xtherapeutic use |
650 | 0 | 4 | _aOutpatients |
650 | 0 | 4 | _aQuality of Life |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aAveryanov, Alexander | |
700 | 1 | _aBart, Boris | |
700 | 1 | _aMinina, Elena | |
700 | 1 | _aPutilovskiy, Mikhail | |
700 | 1 | _aAndrianova, Elena | |
700 | 1 | _aEpstein, Oleg | |
773 | 0 |
_tInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases _gvol. 51 _gp. 47-55 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijid.2016.09.002 _zAvailable from publisher's website |
999 |
_c26408022 _d26408022 |